0000950170-24-102040.txt : 20240829 0000950170-24-102040.hdr.sgml : 20240829 20240829210003 ACCESSION NUMBER: 0000950170-24-102040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240827 FILED AS OF DATE: 20240829 DATE AS OF CHANGE: 20240829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thomson David CENTRAL INDEX KEY: 0001297976 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50865 FILM NUMBER: 241265576 MAIL ADDRESS: STREET 1: 28903 NORTH AVENUE PAINE CITY: VALENCIA STATE: CA ZIP: 91355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANNKIND CORP CENTRAL INDEX KEY: 0000899460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 133607736 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CASPER STREET CITY: DANBURY STATE: CT ZIP: 06810 BUSINESS PHONE: 818-661-5000 MAIL ADDRESS: STREET 1: 1 CASPER STREET CITY: DANBURY STATE: CT ZIP: 06810 4 1 ownership.xml 4 X0508 4 2024-08-27 0000899460 MANNKIND CORP MNKD 0001297976 Thomson David 1 CASPER STREET DANBURY CT 06810 false true false false EVP Genl Counsel & Secretary true Common Stock, $0.01 Par Value 2024-08-27 4 F false 22489 5.38 D 835396 D Common Stock, $0.01 Par Value 2024-08-29 4 S false 5553 5.94 D 829843 D Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of previously reported restricted stock units. Transaction occurred pursuant to Rule 10b5-1 Plan established September 5, 2023. /s/ David Thomson 2024-08-29